Skip to main
MDAI

MDAI Stock Forecast & Price Target

MDAI Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Spectral AI Inc is poised for substantial financial growth, with expectations for revenue to increase at a compound annual growth rate (CAGR) of 69% or more from FY26 through FY30, following the commercial launch of its DeepView System. The company has also improved its research and development revenue forecasts significantly, projecting revenues of $18.5 million for FY26, a substantial increase from prior estimates. Additionally, Spectral AI's licensing model is anticipated to generate recurring revenue at high margins, positioning the company favorably for stable and predictable growth in the MedTech industry.

Bears say

Spectral AI Inc has reduced its FY25 BARDA revenue guidance to approximately $18.5 million, reflecting a year-over-year decline of 37.6% from the prior $21.5 million forecast, primarily due to timing issues with the BARDA contract and the impact of a government shutdown. The company anticipates further revenue declines in FY26, having not provided specific guidance but indicating that revenue is expected to be lower than FY25 levels. Additionally, the potential for extended clinical and regulatory development timelines poses a risk to future BARDA-related revenue, further contributing to a negative financial outlook for Spectral AI.

MDAI has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Spectral AI Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Spectral AI Inc (MDAI) Forecast

Analysts have given MDAI a Strong Buy based on their latest research and market trends.

According to 1 analysts, MDAI has a Strong Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $3, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $3, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Spectral AI Inc (MDAI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.